biguanides has been researched along with Myocardial Ischemia in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Margolis, DJ | 1 |
Hoffstad, O | 1 |
Strom, BL | 1 |
Monami, M | 1 |
Marchionni, N | 1 |
Masotti, G | 1 |
Mannucci, E | 1 |
2 other studies available for biguanides and Myocardial Ischemia
Article | Year |
---|---|
Association between serious ischemic cardiac outcomes and medications used to treat diabetes.
Topics: Adult; Aged; Biguanides; Cohort Studies; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Ins | 2008 |
Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart disease.
Topics: Aged; Biguanides; Cohort Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Foll | 2008 |